Mycoplasma pneumonia in children of the amur region. Search for clinical and laboratory features

Abstract

The prevalence of mycoplasma infection, including pneumonia, remains a pressing problem throughout the world. The purpose of the study is to study primary respiratory mycoplasmosis with the aim of early verification of this diagnosis and determination of the initiation of therapy. A retrospective study was conducted of 100 case histories of children aged 2 to 18 years who were discharged from the gastroenterology department of the Amur Regional Children’s Clinical Hospital in 2023 with a diagnosis of Pneumonia. The clinical picture, diagnosis and treatment of bacterial community-acquired pneumonia caused by mycoplasma pneumoniae (50 people - group 1) and pneumonia caused by typical pathogens (50 people - comparison group 2) were assessed. To verify the diagnosis of pneumonia, chest radiography was additionally used; to identify the mycoplasma etiology of the disease, positive levels of IgM and/or A were detected. Mycoplasma pneumonia (MP) and community-acquired pneumonia of other etiologies (CAP) are equally more common in children aged 12 to 18 years (p>0.05). Dry rales and fine wheezing occurred with equal frequency in the two groups. In MP, bilateral lung damage is more common (p<0.01), occurring with a dry cough (in 76% of children). Children with CAP, however, were significantly more likely to be diagnosed with stage 1 respiratory failure (RF) (p<0.01). From laboratory data, more than half of the children in group 1 (56%) had monocytosis, and in a third of cases (32%) there was eosinophilia. However, clear and reliable clinical and laboratory criteria for MP were not obtained in our study